Approval of Brazil President Luiz Inacio Lula da Silva's government remained stable in September, although his rejection rate increased, according to a poll published on Thursday.
The survey by Datafolha showed positive approval of the government rose slightly to 38% of respondents from 37% in June, while negative views rose from 27% to 31%.
Approval of Lula's performance as president after the first eight months of his term is higher than former President Jair Bolsonaro's, who had a 29% approval rate at the same point in 2019. Optimism over the future of Lula's government decreased to 43% from 50% in March, while 28% are pessimistic about his government, up from 21% seen in March.
Datafolha interviewed 2,016 people of voting age between Sep. 12-13. The poll has a margin of error of 2.0 percentage points.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Food, music and weed: Cannabis cafes await Newsom's stamp of approvalCalifornia lawmakers have approved Amsterdam-style cannabis cafes. They'll open by 2024 if OK'd by the governor.
Read more »
Dr. Abisola Olulade on the FDA's approval of another COVID-19 booster shot -SAN DIEGO (KUSI) – The FDA approved another COVID-19 booster shot as we enter flu season. Dr. Abisola Olulade joined KUSI’s Logan Byrnes to explain why she believes people need to get one more booster to stay safe, despite acknowledging they have “booster fatigue.” Dr. Olulade said “COVID-19 is very much still a thing, it is very much still around,...
Read more »
Country Garden gets maturity extension approval for one more onshore bond -sources By ReutersCountry Garden gets maturity extension approval for one more onshore bond -sources
Read more »
Country Garden gets maturity extension approval for one more onshore bondCountry Garden has won approval from its creditors to extend the maturity of one more onshore bond, sources with knowledge of the matter said, as the Chinese developer battles to avoid a default amid Beijing's efforts to stabilise the crisis-hit sector.
Read more »
Moderna says flu vaccine showed promising results in phase three trial, paving path to approvalModerna compared the flu vaccine, dubbed mRNA-1010, to a currently approved seasonal flu vaccine from GlaxoSmithKline called Fluarix.
Read more »